Finally, the decrease in cell viability observed in organoid models upon treatment with encorafenib or doublet correlated with an increase in apoptosis mediated by caspase 3/7 activation at 48 hours in BRAFV600E colorectal cancer and in both PMP models (Fig. 3B). The gene discussed is CASP3; the disease is colorectal cancer.